Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats

Brain Research
W M ZawadaC R Freed

Abstract

Embryonic dopamine neurons survive poorly after transplant into models of Parkinson's disease, possibly due to programmed cell death (apoptosis). Apoptosis in cultured dopamine neurons can be reduced by growth factors such as glial cell line-derived neurotrophic factor (GDNF) or a combination of insulin-like growth factor-I (IGF-I) and basic fibroblast growth factor (bFGF). To improve the survival of dopamine neurons in grafts, strands of E15 rat ventral mesencephalon were pretreated with a combination of GDNF, IGF-I, and bFGF and then transplanted into 6-hydroxydopamine-lesioned rats. In control animals, only 32% of dopamine neuron profiles survived the first 24 h after transplant. Growth factor pretreatment increased survival to 49% on day 1. Growth factors reduced the apoptotic rate of transplanted cells, just as they had in the previous in vitro experiments. Apoptotic nuclear morphology was observed in the transplanted dopamine neurons. We conclude that the majority of transplanted dopamine neurons die in grafts within the first 24 h after transplant, most likely by an apoptotic mechanism. Prevention of apoptosis with anti-apoptotic agents may improve the viability of dopamine neurons grafted for Parkinson's disease.

References

Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
May 1, 1990·Archives of Neurology·C R FreedD A Rottenberg
Oct 24, 1985·Neuroscience Letters·P BrundinA Björklund
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·A MacayaR E Burke
Jul 1, 1996·Experimental Neurology·W M ZawadaC R Freed
Dec 29, 1995·Neuroreport·E D ClarksonC R Freed
Feb 1, 1946·The Anatomical Record·M ABERCROMBIE

❮ Previous
Next ❯

Citations

Nov 28, 2007·Cell and Tissue Research·Tomoaki Ikeda
Oct 15, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Curt R FreedRobert E Breeze
Jun 2, 2005·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Ling WeiShan Ping Yu
Feb 11, 2004·Experimental Neurology·Diana CasperAnn Pidel
Mar 22, 2003·Journal of Neuroscience Methods·A E PeaireJohn W Commissiong
Apr 12, 2002·Brain Research. Developmental Brain Research·Laura ColombaioniMercedes Garcia-Gil
Dec 29, 1999·Neuroscience·G S Kaminski SchierleP Brundin
Jun 1, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A L BrownellO Isacson
Jun 8, 2001·Progress in Retinal and Eye Research·R D LundJ M Lawrence
Dec 19, 1998·Molecular Medicine Today·A E WillingP R Sanberg
Jun 28, 2003·Neurotoxicity Research·Alba I RodríguezPaul R Sandberg
Jul 31, 2002·Congestive Heart Failure·Jochen Müller-EhmsenRobert A Kloner
May 13, 2011·American Journal of Physiology. Cell Physiology·Xinyang HuShan Ping Yu
Dec 18, 2013·Journal of Molecular Cell Biology·Clare L Parish, Lachlan H Thompson
Jul 31, 2001·Experimental Neurology·C E HeltA C Granholm
Jul 3, 2002·Experimental Neurology·Deborah J Clarke, Richard L Branton
Jul 19, 2011·Journal of Aging Research·Dimitrios Adamis, David Meagher
Sep 27, 2014·Bulletin of Experimental Biology and Medicine·E S PetrovaD E Korzhevskii

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis